Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8 years. Yaxley WJ, Mackean J, Desai DJ, Tsang G, et al. BJU Int 2022;130 Suppl 3:40-45.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yaxley WJ, Mackean J, Desai DJ, Tsang G, et al. Oncological and urinary outcomes following low-dose-rate brachytherapy with a median follow-up of 11.8 years. BJU Int 2022;130 Suppl 3:40-45.
PMID: 35791775